Home / Life sciences

Category: Life sciences

Rockstone’s iQ Spaces to build Berlin’s gene therapy centre

Rockstone Capital Partners life science platform subsidiary iQ spaces is to develop the €180m Berlin Center for Gene and Cell Therapies, a project initiated by Bayer AG and the Charité - Universitätsmedizin Berlin.
40/40 items shown

Feldberg to shine life sciences light on Berlin’s Osram-Höfe

UK Crown’s £1.5bn life science JV takes on former Oxford retail

Knight Frank: take-up in life sciences Golden Triangle +25%

Savills: new boost needed for the Dutch life sciences sector

Nuveen loan to enable building of Amsterdam life science asset

KF: lack of lab space hindering life sciences’ growth in London

Life Science REIT sells Lumen House, hails UK opportunities

More specialist space needed if UK to grasp life science chance

Aviva and Socius to develop a £1 billion London Cancer Hub

Breakthrough to develop new biotech facility in Amsterdam

More science space needed for UK’s depleted ‘golden triangle’

Listed London office landmark to be reborn as life science hub

Canary Wharf life science development gets green light

Germany faces shortage of life science and tech space by 2025

Oxford boosts life science arm with $125m Boston acquisition

Oxford Uni and Legal & General deliver new life sciences space

GIC and BA pension fund join London life science project

€1bn Oxford and Novaxia JV acquires Paris science campus

Great opportunities in science parks sector in the Netherlands

Innovation centre adds weight to Canary Wharf science plans

Mission Street & BGO to deliver science campus in Cambridge

Creating a space where the brightest minds converge

Paul Strohm

iQ spaces: new life sciences platform launched in Germany

Canary Wharf to host Europe’s largest commercial laboratory

How the life sciences sector is levelling up the UK’s north

Nicol Dynes

How to combine innovation with positive social impact

‘Triple helix’ key to Glasgow Life Sciences hub’s success

Space the only constraint to the growth of Life Sciences

Life Science REIT completes its IPO, raising £350 million

Axa IM Alts boosts life science strategy with additional €1.9bn

Property to track ‘exceptional’ corporate spend on life science

CPP Investments & Lendlease in €400 million JV in Milan

Oxford buys first asset in £1.2bn European life science strategy

European life science debut in Denmark’s Medicon Valley

Life sciences sector poised for take-off across Europe

Nicol Dynes

US capital keen to invest in life sciences sector in the UK

Scotland to benefit as life sciences attract investors

Axa gains access and scale in European life science sector

Dutch Bouwinvest buys €50m stake in US life science space